Morgan Stanley filings document the company’s financial services business, capital structure, governance and material events. The record includes 8-K reports for current events, proxy materials for annual meeting and shareholder voting matters, and securities listings covering common stock, depositary preferred shares and medium-term notes associated with Morgan Stanley Finance LLC.
Filings also disclose governance procedures, registered security classes, NYSE listing information, preferred stock series, debt-security registration matters and formal status changes such as a Form 25 notice for removal of a listed note class from exchange registration.
Morgan Stanley Finance LLC is offering Contingent Income Memory Auto-Callable Securities due December 22, 2028, fully and unconditionally guaranteed by Morgan Stanley. These principal-at-risk notes are linked to the worst performer of the S&P 500 Index, the Russell 2000 Index and the Nasdaq-100 Technology Sector Index. Investors may receive a contingent coupon at an annual rate of 9.50% on scheduled payment dates, but only if on each observation date all three indexes close at or above their coupon barrier levels, set at 80% of initial levels. The notes can be automatically redeemed starting with the December 21, 2026 redemption determination date if all indexes are at or above 100% of their initial levels, returning principal plus the applicable coupon and any unpaid coupons. If held to maturity and all final index levels are at or above 60% of initial levels, investors receive the stated principal amount plus any due coupons; otherwise, repayment is reduced by 1% of principal for every 1% decline in the worst-performing index from its initial level, and the maturity payment could be zero. The estimated value on the pricing date is approximately $986.80 per $1,000 security.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is issuing $1,000-denomination Buffered Jump Securities due December 8, 2027. The $1,000,000 principal-at-risk notes are linked to an equal-weight basket of AbbVie, Eli Lilly, Regeneron, Vertex and UnitedHealth.
The notes pay no interest and do not guarantee principal. They auto-call on December 16, 2026 if the basket is at or above 100% of its initial level, returning $1,106 per note. If held to maturity and the basket finishes above its initial level, investors receive $1,000 plus 125% of the basket’s gain. If the final level is between 80% and 100%, principal is returned. Below the 80% buffer, losses are amplified by a 1.25 downside factor and repayment can fall to zero.
The estimated value on the pricing date is $965.30 per $1,000 note, reflecting fees, hedging and Morgan Stanley’s internal funding rate. The securities are unsecured, subject to Morgan Stanley’s credit, not listed on an exchange and not insured by the FDIC.
Morgan Stanley Finance LLC is offering $2,229,000 of Jump Securities with an auto-callable feature, fully and unconditionally guaranteed by Morgan Stanley and linked to the worst performer of the S&P 500 Index, Nasdaq-100 Index and S&P 500 Equal Weight Index. Each security has a $1,000 stated principal amount, pays no interest and does not guarantee a return of principal.
The notes may be automatically redeemed starting December 7, 2026 if all three indexes are at or above 100% of their initial levels, for fixed early redemption payments rising from $1,102 to $1,459 per $1,000 depending on the call date, corresponding to about a 10.20% annualized return. If held to December 9, 2030 and all final index levels are at or above 80% of their initial levels, investors receive $1,510 per $1,000; if any index is below 80% but all are at or above 75%, only principal is returned; if any index finishes below 75%, repayment is reduced 1% for each 1% decline in the worst index and can be zero.
The securities are unsecured obligations subject to the credit risk of Morgan Stanley Finance LLC and Morgan Stanley, will not be listed on any exchange and may have limited secondary market liquidity. The estimated value on the pricing date is $978.40 per security, below the $1,000 issue price, reflecting issuing, selling, structuring and hedging costs and the issuer’s internal funding rate.
Morgan Stanley Finance LLC is offering $1,300,000 of Contingent Income Auto-Callable Securities due May 27, 2027, linked to Micron Technology, Inc. common stock and fully guaranteed by Morgan Stanley. These principal-at-risk structured notes are issued at $1,000 per security, with an estimated value on the pricing date of $963.80 per security, reflecting issuing, selling, structuring and hedging costs and an internal funding rate.
The notes may pay a contingent coupon at an annual rate of 18.50% on scheduled coupon payment dates if Micron’s closing share price is at or above the $134.718 coupon barrier (60% of the $224.53 initial level) on the related observation date. They are automatically redeemed at par plus that period’s coupon if, on specified redemption determination dates starting February 25, 2026, Micron closes at or above the $190.851 call threshold (85% of the initial level).
If not called, and on the final observation date Micron is at or above the $112.265 downside threshold (50% of the initial level), investors receive the stated principal amount plus any final coupon. If the final level is below this threshold, repayment is reduced in proportion to Micron’s decline and can fall to zero, so investors may lose their entire principal. All payments depend on Morgan Stanley’s credit, the securities are unsecured and unlisted, and secondary market liquidity may be limited.
Morgan Stanley Finance LLC is offering $1,200,000 of callable contingent income memory securities due June 9, 2027, linked to the S&P 500, Nasdaq-100 and Russell 2000 indexes.
The notes pay a 9.84% annual contingent coupon, but only when each index closes at or above 75% of its initial level on scheduled observation dates; missed coupons can be paid later if these barriers are met.
Principal is fully at risk: if, at maturity, any index is below its downside threshold (75% of its initial level), the repayment is reduced 1% for each 1% decline of the worst performer and can fall to zero. The securities are unsecured, not listed on an exchange, may trade below the $1,000 issue price, and had an estimated value of $978.90 on the pricing date.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering auto-callable “Jump Notes” due December 15, 2028 linked to the worst performer of the VanEck® Gold Miners ETF (GDX) and iShares® Silver Trust (SLV). The notes have a $1,000 stated principal amount, no periodic interest, and an estimated value on the pricing date of approximately $963 per note.
The notes can be automatically redeemed early if on a determination date both underliers are at or above their call threshold levels, paying $1,070 per note on December 18, 2026 or $1,140 on December 16, 2027, corresponding to about a 7.00% per annum return. If not called, and on the final determination date both underliers meet or exceed their thresholds, investors receive $1,210 per note at maturity; otherwise they receive only the $1,000 principal. Payments are subject to Morgan Stanley’s credit risk, the notes will not be listed on any exchange, and investors face product-specific risks including limited upside, early redemption risk, complex valuation, exposure to gold-mining equities and silver, and treatment as contingent payment debt instruments for U.S. tax purposes.
Morgan Stanley Finance LLC is offering $2,039,000 of Enhanced Buffered Jump Securities due November 20, 2026, fully and unconditionally guaranteed by Morgan Stanley. Each $1,000 principal-at-risk note pays no interest and is linked to the worst performer among the S&P 500® Futures Excess Return Index, the Utilities Select Sector SPDR® Fund and the Russell 2000® Index.
At maturity, investors receive $1,000 plus a fixed digital payment of $121 (12.10%) per note if the final level of each underlier is at or above its digital threshold level, set at about 75% of its initial level. Principal is protected only down to a 10% buffer; if any underlier finishes below its buffer level (90% of its initial level), repayment is reduced by 1% for each 1% decline of the worst performer beyond that buffer, with a minimum payment of 10% of principal.
The securities are unsecured obligations subject to Morgan Stanley’s credit risk, will not be listed on an exchange, and are expected to have limited liquidity. The estimated value on the October 20, 2025 pricing date is $987.90 per $1,000, reflecting issuance, structuring and hedging costs and an internal funding rate advantageous to the issuer.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering principal-at-risk “Step-Down Contingent Income Memory Auto-Callable Securities” due December 12, 2030, linked to the S&P 500 Futures 40% Intraday 4% Decrement VT Index. Each note has a stated principal amount and issue price of $1,000, with an estimated value on the pricing date of about $925.80 per security.
The notes pay a 13.00% annual contingent coupon, but only on observation dates when the index closes at or above a barrier set at 70% of its initial level; missed coupons can be paid later if the barrier is met. Starting December 9, 2026, the notes can be automatically redeemed on specified redemption determination dates if the index is at or above step-down call thresholds, returning principal plus the applicable coupon and any previously unpaid contingent coupons.
If the notes are not called and the final index level is at or above a downside threshold of 50% of the initial level, investors receive their principal back plus any payable coupons. If the final level is below that threshold, repayment is reduced in line with the index loss, up to a total loss of principal. Investors also face the credit risk of Morgan Stanley and structural risks from the leveraged, 4% decrement index, which has limited live performance history.
Morgan Stanley Finance LLC is offering principal-at-risk Buffered Jump Securities with an auto-call feature maturing on December 9, 2027, fully and unconditionally guaranteed by Morgan Stanley. Each security has a stated principal amount of $1,000 and does not pay interest.
The notes are linked to an equally weighted basket of AbbVie, Eli Lilly, Regeneron, Vertex and UnitedHealth stocks. If, on December 18, 2026, the basket level is at or above its initial level, the notes are automatically redeemed for $1,102 per security and terminate. If held to maturity and the final basket level is above the initial level, investors receive principal plus 125% of the basket’s gain.
A 20% downside buffer applies; if the final level is between 80% and 100% of the initial level, investors receive only their $1,000 principal. Below 80%, losses accelerate at 1.25% of principal for each 1% decline beyond the buffer, and the repayment can be reduced to zero. The estimated value on the pricing date is approximately $961.60 per security, and investors face issuer credit risk, limited liquidity and complex U.S. tax treatment.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering leveraged buffered notes linked to the S&P 500 Index under its medium-term note program. The notes do not pay interest and return at maturity depends solely on index performance between the trade date and a determination date expected 13–15 months later.
For each $1,000 note, investors receive 160% of any positive index return, but gains are capped by a maximum settlement amount expected between $1,115.20 and $1,135.52. A 10% downside buffer protects against moderate declines: if the index falls by up to 10%, investors receive $1,000. Below that, principal is reduced with a buffer rate of about 111.11%, and all principal can be lost.
The notes are unsecured and subject to the issuer’s and guarantor’s credit risk, will not be listed on any exchange, and may have limited or no secondary market. The estimated value on the trade date is approximately $992.50 per note, reflecting issuing, selling, structuring and hedging costs and the issuer’s internal funding rate. Tax treatment is uncertain and could differ from the issuer’s expectations.